{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T16:31:38Z","timestamp":1794241898068,"version":"4.9.0"},"reference-count":16,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,3,19]],"date-time":"2009-03-19T00:00:00Z","timestamp":1237420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2009,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Objective\u2002<\/jats:bold> Depot luteinizing\u2010hormone releasing hormone (LHRH) agonist have been widely used for the treatment of central precocious puberty (CPP), but the optimal doses to obtain hormonal suppression are still unknown, especially in patients with higher weights. The goal of our study was to compare the efficacy of three leuprolide acetate (LA) preparations, suppressing gonadotropin secretion in patients with CPP.<\/jats:p><jats:p><jats:bold>Design\u2002<\/jats:bold> In an open 12\u2010month protocol, we evaluated LA 7\u00b75\u2003mg\/month, 11\u00b725 and 22\u00b75 every 3\u2003months.<\/jats:p><jats:p><jats:bold>Patients\u2002<\/jats:bold> Fourteen girls with CPP and weights over 30\u2003kg.<\/jats:p><jats:p>Measurements: Clinical, radiological and laboratory follow\u2010up: GnRH test plus LH, FSH 40\u2003min post analogue was performed periodically.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Pretreatment basal and LHRH stimulated LH levels between groups were not different. Basal and LHRH stimulated LH levels decreased significantly between baseline and from 3 up to 12\u2003months of therapy in all groups (<jats:italic>P\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>0\u00b7001). GnRH stimulated LH peak &lt;2\u2003IU\/l, the main efficacy criterion was met in 80, 75 and 100% of the children at 6\u2003months in the 7\u00b75, 11\u00b725, 22\u00b75\u2003mg doses respectively. By 12\u2003months, 100% of patients had LH suppressed to &lt;2\u2003IU\/l.<\/jats:p><jats:p><jats:bold>Conclusions\u2003<\/jats:bold> These results affirm that 3\u2010month injections may be a satisfactory alternative for the therapy of children with CPP to avoid monthly injections. In addition, suppression of LH occurs sooner in the 3\u2010month 22\u00b75\u2003mg LA dose compared to the 3\u2010month 11\u00b75\u2003mg; therefore, adequate dosing may be important for optimal outcome. Further investigation is needed in more patients over 30\u2003kg, with longer treatment duration, and ultimately final height consideration.<\/jats:p>","DOI":"10.1111\/j.1365-2265.2009.03584.x","type":"journal-article","created":{"date-parts":[[2009,3,19]],"date-time":"2009-03-19T10:00:11Z","timestamp":1237456811000},"page":"686-690","source":"Crossref","is-referenced-by-count":27,"title":["Comparison of three doses of leuprolide acetate in the treatment of central precocious puberty: preliminary results"],"prefix":"10.1111","volume":"71","author":[{"given":"Ver\u00f3nica","family":"Mericq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Javier","family":"Lammoglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Unanue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Villaroel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Isabel","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"\u00c1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germ\u00e1n","family":"I\u00f1iguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Oerter","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,10,5]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.2165\/00024677-200201050-00002"},{"issue":"2","key":"e_1_2_7_3_2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1210\/jcem.84.2.5533","article-title":"Precocious puberty: who has it? Who should be treated?","volume":"84","author":"Klein K.O.","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"5","key":"e_1_2_7_4_2","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1210\/jc.2005-1500","article-title":"Sequential comparisons of one\u2010month and three\u2010month depot leuprolide regimens in central precocious puberty","volume":"91","author":"Badaru A.","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"7","key":"e_1_2_7_5_2","first-page":"821","article-title":"Effectiveness of Leuprolide acetate therapy every three months in central precocious puberty","volume":"134","author":"Mericq G.M.V.","year":"2006","journal-title":"Revista Medica de Chile"},{"issue":"9","key":"e_1_2_7_6_2","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1210\/jc.2001-020243","article-title":"Treatment of central precocious puberty by subcutaneous injections of leuprorelin 3\u2010month depot (11.25\u2003mg)","volume":"87","author":"Carel J.","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"4","key":"e_1_2_7_7_2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1507\/endocrj1954.38.369","article-title":"A dose finding study of a super long\u2010acting luteinizing hormone\u2010releasing hormone analog (leuprolide acetate depot, TAP\u2010144\u2010SR) in the treatment of central precocious puberty. The TAP\u2010144\u2010SR CPP Study Group","volume":"38","author":"Tanaka T.","year":"1991","journal-title":"Endocrinologia Japonica"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(95)70254-7"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1995.tb13689.x"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1998.tb00921.x"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcu.20522"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117616"},{"issue":"12","key":"e_1_2_7_13_2","first-page":"4536","article-title":"A single sample subcutaneous luteinizing hormone (LH)\u2010releasing hormone (LHRH) stimulation test for monitoring LH suppression in children with central precocious puberty receiving LHRH agonists","volume":"84","author":"Lawson M.","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"5","key":"e_1_2_7_14_2","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1515\/JPEM.2004.17.5.759","article-title":"Accelerated versus slowly progressive forms of puberty in girls with precocious and early puberty. Gonadotropin suppressive effect and final height obtained with two different analogs","volume":"17","author":"Lanes R.","year":"2004","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1994.tb12984.x"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.2007.20.11.1189"},{"issue":"4","key":"e_1_2_7_17_2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000100579","article-title":"Efficacy of a monthly compared to 3\u2010monthly depot GnRH analogue (goserelin) in the treatment of children with central precocious puberty","volume":"68","author":"Isaac H.","year":"2007","journal-title":"Hormone Research"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2009.03584.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.2009.03584.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T14:26:28Z","timestamp":1697379988000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2009.03584.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,5]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["10.1111\/j.1365-2265.2009.03584.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03584.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,5]]}}}